ArticlebioRxiv : the preprint server for biology2024

Development of quantitative high-throughput screening assays to identify, validate, and optimize small-molecule stabilizers of misfolded β-glucocerebrosidase with therapeutic potential for Gaucher disease and Parkinson's disease.

Darian Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.